The Efficacy of a Plant Based Formulation in the Symptomatic Management of Mild COVID-19 Cases: A Double Blind, Randomized Controlled Trial. Archives of Clinical and Medical Case Reports, v. 7, n. 1, p. 5–12, 18 Jan.2023.